• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名儿科患者的意外合成大麻素中毒:病例报告

Accidental Synthetic Cannabinoid Poisoning in a Pediatric Patient: A Case Report.

作者信息

Gonedes Andrew J, Boccio Eric

机构信息

Emergency Medicine, Memorial Healthcare System, Hollywood, USA.

出版信息

Cureus. 2024 Dec 1;16(12):e74936. doi: 10.7759/cureus.74936. eCollection 2024 Dec.

DOI:10.7759/cureus.74936
PMID:39744299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11688573/
Abstract

A six-year-old boy presented to the pediatric emergency department following an accidental ingestion of a synthetic cannabinoid. The child ingested an edible product containing tetrahydrocannabinol (THC) and presented with lethargy, altered mental status, and increased muscle tone. The airway was protected, and the patient was breathing spontaneously. Initial assessment included a thorough history provided by the caregivers, which confirmed ingestion of cannabinoid gummies approximately two hours prior to presentation. An electrocardiogram demonstrated sinus tachycardia with a prolonged QTc. Toxicology screening was presumed positive for cannabinoids. Therapeutic management focused on supportive care. The patient was admitted to the hospital and discharged on hospital day two with no neurologic sequelae. The caregivers were provided with expectant management and counseled regarding safe storage and use of cannabis and cannabis-derived products. This case report discusses the growing incidence of cannabis exposure in the pediatric population while highlighting the biochemistry, clinical presentation, and therapeutic management of accidental ingestion of synthetic cannabinoids.

摘要

一名六岁男童在意外摄入合成大麻素后被送往儿科急诊科。该儿童摄入了一种含四氢大麻酚(THC)的可食用产品,出现嗜睡、精神状态改变和肌张力增加。气道得到保护,患者自主呼吸。初始评估包括护理人员提供的详细病史,证实该儿童在就诊前约两小时摄入了大麻软糖。心电图显示窦性心动过速,QTc间期延长。毒理学筛查推测大麻素呈阳性。治疗管理重点在于支持性护理。患者入院,在住院第二天出院,无神经后遗症。向护理人员提供了预期管理,并就大麻及大麻衍生产品的安全储存和使用进行了咨询。本病例报告讨论了儿科人群中大麻暴露发生率的上升,同时强调了意外摄入合成大麻素的生物化学、临床表现及治疗管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e27/11688573/e3c8bf89a043/cureus-0016-00000074936-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e27/11688573/e3c8bf89a043/cureus-0016-00000074936-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e27/11688573/e3c8bf89a043/cureus-0016-00000074936-i01.jpg

相似文献

1
Accidental Synthetic Cannabinoid Poisoning in a Pediatric Patient: A Case Report.一名儿科患者的意外合成大麻素中毒:病例报告
Cureus. 2024 Dec 1;16(12):e74936. doi: 10.7759/cureus.74936. eCollection 2024 Dec.
2
Unintentional Marijuana Exposure Presenting as Altered Mental Status in the Pediatric Emergency Department: A Case Series.儿科急诊科中因意外接触大麻而出现精神状态改变:病例系列
J Emerg Med. 2017 Dec;53(6):e119-e123. doi: 10.1016/j.jemermed.2017.08.007. Epub 2017 Oct 5.
3
Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies.摄入 δ-8-四氢大麻酚软糖后小儿患者镇静和急性脑病。
Am J Case Rep. 2021 Nov 11;22:e933488. doi: 10.12659/AJCR.933488.
4
Acute Toxicity With Lactic Acidosis Associated With Cannabinoid Gummies.与大麻软糖相关的急性毒性伴乳酸性酸中毒
Cureus. 2024 Oct 27;16(10):e72495. doi: 10.7759/cureus.72495. eCollection 2024 Oct.
5
A Case of Toxicity from Cannabidiol Gummy Ingestion.一例因摄入大麻二酚软糖而导致中毒的病例。
Cureus. 2020 Apr 16;12(4):e7688. doi: 10.7759/cureus.7688.
6
Unintentional ingestion of putative delta-8 tetrahydrocannabinol by two youth requiring critical care: a case report.两名青少年意外摄入疑似δ-8四氢大麻酚并需要重症监护:一例报告
J Cannabis Res. 2023 Mar 21;5(1):9. doi: 10.1186/s42238-023-00176-x.
7
Marijuana poisoning.大麻中毒
Top Companion Anim Med. 2013 Feb;28(1):8-12. doi: 10.1053/j.tcam.2013.03.004.
8
Pediatric Poisonings Associated With Ingestion of Marijuana Products.与摄入大麻制品相关的儿童中毒
J Emerg Med. 2023 Feb;64(2):181-185. doi: 10.1016/j.jemermed.2022.12.025. Epub 2023 Feb 21.
9
Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.大麻素暴露与食用型大麻产品中 THC 和 CBD 的主观效应。
Cannabis Cannabinoid Res. 2024 Feb;9(1):320-334. doi: 10.1089/can.2022.0020. Epub 2022 Nov 15.
10
Accidental Ingestion of Tetrahydrocannabinol-Laced Gummies Causing Bradycardia and First-Degree Atrioventricular Block in a Pediatric Patient: A Case Report.小儿患者意外摄入含四氢大麻酚的软糖致心动过缓和一度房室传导阻滞:一例报告
Cureus. 2022 Jul 13;14(7):e26826. doi: 10.7759/cureus.26826. eCollection 2022 Jul.

引用本文的文献

1
Acute cannabis intoxication among the paediatric population.儿科人群中的急性大麻中毒。
Front Toxicol. 2025 Apr 14;7:1558721. doi: 10.3389/ftox.2025.1558721. eCollection 2025.
2
Young Age and Concomitant Cannabis (THC) and Ethanol (EtOH) Exposure Enhances Rat Brain Damage Through Decreased Cerebral Mitochondrial Respiration.年轻时同时接触大麻(四氢大麻酚)和乙醇会通过降低脑线粒体呼吸作用增强大鼠脑损伤。
Molecules. 2025 Feb 17;30(4):918. doi: 10.3390/molecules30040918.

本文引用的文献

1
The Potential of Cannabichromene (CBC) as a Therapeutic Agent.大麻色烯(CBC)作为治疗剂的潜力。
J Pharmacol Exp Ther. 2024 Oct 18;391(2):206-213. doi: 10.1124/jpet.124.002166.
2
Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America's Poison Centers.向美国毒物控制中心报告的δ-8四氢大麻酚、δ-10四氢大麻酚和四氢大麻酚-O乙酸酯暴露情况。
Clin Toxicol (Phila). 2024 Apr;62(4):256-266. doi: 10.1080/15563650.2024.2340115. Epub 2024 Apr 30.
3
Cannabis Toxicity in Children and Adolescents.
儿童和青少年大麻中毒。
Pediatr Ann. 2023 May;52(5):e181-e186. doi: 10.3928/19382359-20230307-04. Epub 2023 May 1.
4
Delta-8 tetrahydrocannabinol: a scoping review and commentary.德尔塔-8 四氢大麻酚:范围综述和评论。
Addiction. 2023 Jun;118(6):1011-1028. doi: 10.1111/add.16142. Epub 2023 Feb 13.
5
Pediatric Edible Cannabis Exposures and Acute Toxicity: 2017-2021.儿科食用大麻暴露和急性毒性:2017-2021 年。
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-057761.
6
Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial.大麻二酚治疗雷特综合征女孩癫痫的疗效和安全性:一项 1 期临床试验。
Epilepsia. 2022 Jul;63(7):1736-1747. doi: 10.1111/epi.17247. Epub 2022 Apr 20.
7
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder.大麻二酚治疗癫痫和自闭症谱系障碍的潜力。
Pharmacol Ther. 2021 Oct;226:107878. doi: 10.1016/j.pharmthera.2021.107878. Epub 2021 Apr 22.
8
The Pharmacological Case for Cannabigerol.大麻素二醇的药理学案例。
J Pharmacol Exp Ther. 2021 Feb;376(2):204-212. doi: 10.1124/jpet.120.000340. Epub 2020 Nov 9.
9
Cannabidivarin for HIV-Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial.大麻二酚治疗 HIV 相关神经性疼痛:一项随机、双盲、对照临床试验。
Clin Pharmacol Ther. 2021 Apr;109(4):1055-1062. doi: 10.1002/cpt.2016. Epub 2020 Sep 6.
10
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ-tetrahydrocannabinol: Δ-Tetrahydrocannabiphorol.一种从大麻属植物中分离得到的新型植物大麻素,其体内大麻样活性高于 Δ-四氢大麻酚:Δ-四氢大麻酚醇。
Sci Rep. 2019 Dec 30;9(1):20335. doi: 10.1038/s41598-019-56785-1.